AI assistant
Svenska Cellulosa AB — Earnings Release 2013
Oct 18, 2013
2964_10-q_2013-10-18_720023d0-328e-409c-8e5a-77c00d3da50c.pdf
Earnings Release
Open in viewerOpens in your device viewer
JANUARY 1–SEPTEMBER 30, 2013 (compared with same period a year ago)
- Net sales rose 7% (14% excluding exchange rate effects and divestments) to SEK 66,577m (61,963)
- Operating profit excluding items affecting comparability rose 11% (15% excluding exchange rate effects) to SEK 6,885m (6,224)
- Profit before tax, excluding items affecting comparability, rose 17% (21% excluding exchange rate effects) to SEK 6,140m (5,253)
- Items affecting comparability amounted to SEK -1,024m (-1,441)
- Earnings per share were SEK 5.28 (4.09)
- Cash flow from current operations was 4,060m (5,607)
Earnings trend
| SEK m | 1309 | 1209 | % | 2013:3 | 2012:3 | % |
|---|---|---|---|---|---|---|
| Net sales | 66,577 | 61,963 | 7 | 22,046 | 22,200 | -1 |
| Gross profit | 16,421 | 15,125 | 9 | 5,663 | 5,162 | 10 |
| Operating profit1 | 6,885 | 6,224 | 11 | 2,524 | 2,285 | 10 |
| Financial items | -745 | -971 | -268 | -324 | ||
| Profit before tax1 | 6,140 | 5,253 | 17 | 2,256 | 1,961 | 15 |
| Tax1 | -1,628 | -1,481 | -636 | -589 | ||
| Net profit for the period from disposal group | 0 | 503 | 0 | 0 | ||
| Net profit for the period1 | 4,512 | 4,275 | 6 | 1,620 | 1,372 | 18 |
| Earnings per share, SEK | 5.28 | 4.09 | 2.06 | 0.51 |
1 Excluding items affecting comparability; for amounts see page 12.
CEO'S COMMENTS
To further strengthen its position in emerging markets, SCA has made an offer for the Chinese tissue company Vinda and has decided to invest in local production of hygiene products in India.
The efficiency programs in the hygiene and forest products operations are progressing according to plan.
Consolidated net sales for the first nine months of 2013, excluding exchange rate effects and divestments, rose 14% compared with the same period a year ago. The increase is mainly attributable to acquisitions and higher volumes. Operating profit excluding items affecting comparability and exchange rate effects rose 15%. Acquisition in Europe, higher volumes, lower raw material costs and cost savings contributed to the earnings improvement. Operating profit for Personal Care and Tissue, excluding items affecting comparability, divestments and exchange rate effects, rose 9% and 31% respectively. Operating profit for Forest Products, excluding items affecting comparability, decreased by 11%. Profit before tax, excluding items affecting comparability and exchange rate effects, rose 21%.
Consolidated net sales for the third quarter of 2013, excluding exchange rate effects and divestments, rose 6% compared with the same period a year ago. The increase is mainly attributable to higher volumes. Operating profit excluding items affecting comparability, divestments and exchange rate effects rose 12%. Higher volumes and prices along with cost savings contributed to the earnings improvement. The corresponding profit for Tissue rose 22%, while profit for Personal Care decreased by 3%. Operating profit for Forest Products, excluding items affecting comparability, rose 49%. Profit before tax, excluding items affecting comparability and exchange rate effects, rose 18%.
Operating profit for the third quarter of 2013, excluding items affecting comparability, rose 17% compared with the second quarter of 2013.
EARNINGS TREND FOR THE GROUP
| SEK m | 1309 | 1209 | % | 2013:3 | 2012:3 | % |
|---|---|---|---|---|---|---|
| Net sales | 66,577 | 61,963 | 7 | 22,046 | 22,200 | -1 |
| Cost of goods sold | -50,156 | -46,838 | -16,383 | -17,038 | ||
| Gross profit | 16,421 | 15,125 | 9 | 5,663 | 5,162 | 10 |
| Sales, general and administration | -9,536 | -8,901 | -3,139 | -2,877 | ||
| Operating profit1 | 6,885 | 6,224 | 11 | 2,524 | 2,285 | 10 |
| Financial items | -745 | -971 | -268 | -324 | ||
| Profit before tax1 | 6,140 | 5,253 | 17 | 2,256 | 1,961 | 15 |
| Tax1 | -1,628 | -1,481 | -636 | -589 | ||
| Net profit for the period from disposal group | 0 | 503 | 0 | 0 | ||
| Net profit for the period1 | 4,512 | 4,275 | 6 | 1,620 | 1,372 | 18 |
| 1 Excluding items affecting comparability; for amounts see page 12. | ||||||
| Earnings per share, SEK- owners of the parent | ||||||
| - after dilution effects | 5.28 | 4.09 | 2.06 | 0.51 | ||
| Margins (%) | ||||||
| Gross margin | 24.7 | 24.4 | 25.7 | 23.3 | ||
| Operating margin1 | 10.3 | 10.0 | 11.4 | 10.3 | ||
| Financial net margin | -1.1 | -1.6 | -1.2 | -1.5 | ||
| Profit margin1 | 9.2 | 8.4 | 10.2 | 8.8 | ||
| Tax1 | -2.4 | -2.4 | -2.9 | -2.7 | ||
| Net margin1 | 6.8 | 6.0 | 7.3 | 6.1 |
1 Excluding items affecting comparability; for amounts see page 12.
OPERATING PROFIT PER BUSINESS AREA
| SEK m | 1309 | 1209 | % | 2013:3 | 2012:3 | % |
|---|---|---|---|---|---|---|
| Personal Care | 2,420 | 2,296 | 5 | 804 | 847 | -5 |
| Tissue | 4,028 | 3,221 | 25 | 1,498 | 1,275 | 17 |
| Forest Products | 927 | 1,045 | -11 | 420 | 281 | 49 |
| Other | -490 | -338 | -198 | -118 | ||
| Total 1 | 6,885 | 6,224 | 11 | 2,524 | 2,285 | 10 |
1 Excluding items affecting comparability; for amounts see page 12.
OPERATING CASH FLOW PER BUSINESS AREA
| SEK m | 1309 | 1209 | % | 2013:3 | 2012:3 | % |
|---|---|---|---|---|---|---|
| Personal Care | 2,340 | 2,824 | -17 | 1,116 | 1,260 | -11 |
| Tissue | 3,745 | 4,128 | -9 | 1,730 | 1,579 | 10 |
| Forest Products | 593 | 1,069 | -45 | 176 | 583 | -70 |
| Other | -915 | -823 | -620 | -393 | ||
| Total | 5,763 | 7,198 | -20 | 2,402 | 3,029 | -21 |
Net sales
GROUP
MARKET/EXTERNAL ENVIRONMENT
Demand for tissue in Europe and North America showed some growth during the first nine months of 2013 compared with the same period a year ago. Growth in demand for tissue in emerging markets remained good.
Demand for incontinence care products was favorable in Europe during the first nine months of 2013. For feminine care products, demand in Western Europe remained stable. For personal care products, growth was good in emerging markets.
Demand for publication paper in Western Europe declined during the first nine months of the year, which has led to capacity reductions in the market. In Europe, the market balance for solid wood products has improved in 2013, which has led to price increases. Prices for kraftliner in Europe have risen slightly in 2013.
OTHER GROUP INFORMATION
In 2012, the packaging operations were divested on June 30, and on July 19 Georgia-Pacific's European tissue operations were acquired. In addition, the Asian hygiene company Everbeauty was acquired on June 1, 2012, and the remaining 50% of the Chilean hygiene company PISA was acquired on May 1, 2012. The UKbased newsprint facility Aylesford Newsprint was divested on October 2, 2012. In 2013 the Austrian publication paper mill in Laakirchen was divested on April 1, and during the second quarter, the parts of Georgia-Pacific that the European Commission required SCA to sell in connection with its acquisition were divested. In earnings for the comparison period, for the first half of the year the packaging operations are reported on a separate line in the income statement – Net profit for the period from disposal group. The acquisitions are included in the income statement from their respective acquisition dates, while the divestments are included up until their respective divestment dates.
SALES AND EARNINGS
January–September 2013 compared with corresponding period a year ago Net sales rose 7% (14% excluding exchange rate effects and divestments) to SEK 66,577m (61,963). Higher volumes increased sales by 6%, while lower prices primarily for Forest Products decreased sales by 1%. Acquisitions increased sales by 9%, while divestments lowered sales by 4%.
Operating profit, excluding items affecting comparability, rose 11% (15% excluding exchange rate effects) to SEK 6,885m (6,224). Earnings improved as a result of acquisition in Europe, cost savings, higher volumes and lower raw material costs. Lower prices primarily for Forest Products, exchange rate effects and higher energy costs had a negative effect on earnings. The corresponding profit for Personal Care increased by 5% (9% excluding exchange rate effects), while the corresponding profit for Tissue rose 25% (31% excluding exchange rate effects and divestments). Profit for Forest Products fell 11%, despite positive effects from cost-cutting programs and lower raw material costs, as a result of lower prices, higher energy costs, negative exchange rate effects and costs for extended maintenance shutdowns.
Items affecting comparability amounted to SEK -1,024m (-1,441) and consist of restructuring costs for the previously announced efficiency programs, transaction costs for acquisitions and divestments, and integration costs for the Georgia-Pacific acquisition.
Cost savings related to the cost-cutting and efficiency program covering all of SCA's hygiene operations, i.e., Personal Care and Tissue, amounted to SEK 660m during the first nine months of 2013. The savings during the third quarter totaled SEK 270m, which corresponds to an annual rate of approximately EUR 130m. Total cost savings are expected to amount to EUR 300m with full effect in 2015. The program is progressing according to plan.
Financial items decreased to SEK -745m (-971) as a result of lower interest rates
Excluding items affecting comparability 0,0 0
Operating profit and margin
3,0 6,0 9,0 12,0 15,0
and a lower level of net debt. Profit before tax, excluding items affecting comparability, rose 17% (21% excluding exchange rate effects) to SEK 6,140m (5,253). The tax expense excluding the effects of items affecting comparability was SEK 1,628m (1,481).
Net profit for the period excluding items affecting comparability rose 6% (10% excluding exchange rate effects) to SEK 4,512m (4,275). The figure for the yearearlier period included SEK 503m in profit for Packaging. Earnings per share, including items affecting comparability, were SEK 5.28 (4.09).
Third quarter 2013 compared with third quarter 2012
Net sales decreased by 1% (increased by 6% excluding exchange rate effects and divestments) to SEK 22,046m (22,200). Higher volumes increased sales by 6%. Divestments decreased sales by 6%.
Operating profit excluding items affecting comparability rose 10% (12% excluding exchange rate effects) to SEK 2,524m (2,285). Profit was positively affected by higher volumes, higher prices and cost savings.
Profit before tax excluding items affecting comparability rose 15% (18% excluding exchange rate effects) to SEK 2,256m (1,961).
CASH FLOW AND FINANCING
The operating cash surplus amounted to SEK 9,809m (9,160). The cash flow effect of changes in working capital was SEK -1,019m (430), mainly attributable to an increase in receivables. Current capital expenditures amounted to SEK -2,258m (-1,769). The increase is due to the fact that acquired units were not included for the entire comparison period. Operating cash flow amounted to SEK 5,763m (7,198).
Financial items decreased to SEK -745m (-971) as a result of lower interest rates and a lower level of net debt. Tax payments increased to SEK 1,084m (687). Cash flow from current operations decreased to SEK 4,060m (5,607). A higher operating surplus did not fully compensate for a higher level of tied-up working capital and higher capital expenditures for the period compared with a year ago.
Strategic investments totaled SEK -1,213m (-1,363). The net sum of acquisitions and divestments was SEK 614m (3,054). Net cash flow from the divested packaging operations was SEK 0m (468). Payment of the shareholder dividend affected cash flow by SEK -3,193m (-2,982). Net cash flow totaled SEK 268m (4,784).
Net debt has decreased by SEK 1,695m during the year to date and amounted to SEK 31,232m. Excluding pension liabilities, net debt amounted to SEK 28,318m. Net cash flow reduced net debt by SEK 268m. Fair value measurement of pension assets and pension obligations together with fair valuation of financial instruments reduced net debt by SEK 1,382m. Exchange rate movements reduced net debt by SEK 231m. Reclassification of non-current provisions to pension liabilities in accordance with IAS 19 increased net debt by SEK 186m. The debt/equity ratio was 0.52 (0.55 at the start of the year). Excluding pension liabilities, the debt/equity ratio was 0.47 (0.48 at the start of the year). The debt payment capacity was 36% (39%).
As per September 30, 2013, SCA had outstanding commercial paper worth SEK 3,764m maturing within 12 months. Unutilized credit facilities amounted to SEK 17,660m, including SEK 17,345m in long-term facilities. Cash and cash equivalents amounted to SEK 2,518m.
EQUITY
Consolidated equity decreased by SEK 124m during the period, to SEK 60,040m. Net profit for the period increased equity by SEK 3,738m. Equity decreased by SEK 3,193m through payment of the shareholder dividend. Equity increased by SEK 899m after tax as a result of restatement of the net pension liability to fair value. Fair value measurement of financial instruments increased equity by SEK 181m after tax. Exchange rate movements, including the effects of hedges of net investments in foreign assets after tax, reduced equity by SEK 748m. Acquisitions of non-controlling interests, consisting of outstanding minority shares in the German subsidiary SCA Hygiene Products SE (Societas Europeas), reduced equity by SEK 1,001m.
Cash flow from current operations
TAX
A tax expense of SEK 1,628m, corresponding to a tax rate of 27% is reported for the period, excluding items affecting comparability. The tax expense, including items affecting comparability, amounted to SEK 1,378m.
EVENTS DURING THE YEAR
On April 2 SCA completed the divestment of the Austrian publication paper mill in Laakirchen. The initial purchase consideration was EUR 100m, with a possible, maximum earn-out payment of EUR 100m based on a two-year profit-sharing model.
In connection with SCA's acquisition of Georgia-Pacific's European tissue operations in 2012, the European Commission set conditions for the divestment of certain consumer tissue businesses. These divestments were carried out in April of this year and have been approved by the European Commission. The purchase consideration was approximately EUR 100m.
On June 28 SCA implemented a compulsory redemption of minority shares in its German subsidiary SCA Hygiene Products SE, formerly PWA. The purchase price for the shares was approximately SEK 1bn. Final purchase consideration will be established by a German court of law.
On September 9 SCA decided to make a public cash offer for the Chinese tissue company Vinda. The offer is conditional upon SCA achieving an ownership share in Vinda in excess of 50%. SCA is currently the second largest shareholder in Vinda, which is listed on the Hong Kong Exchange. The offer is 11.00 Hong Kong dollars (HKD) per share, corresponding to a premium of approximately 34.5%, based on the average closing price over the last 30 trading days prior to the offer. SCA became a part owner of the tissue manufacturer Vinda in 2007 and currently has a 21.7% holding in the company. Vinda is the third largest tissue company in China, which is the world's second largest tissue market. The complete prospectus for the offer was presented on October 7, which is the date on which the acceptance period commenced. The deal is expected to be completed during the fourth quarter of this year.
On September 12 SCA announced that it will invest approximately SEK 150m in local production of hygiene products in India. The plan calls for production to start at SCA's own plant in 2015. The ambition is to introduce SCA's hygiene products in the Indian market as early as the end of 2013. The brands that SCA will launch include the world-leading brands TENA, for incontinence care products, and Tork, for awayfrom-home (AFH) tissue. The Libero brand of baby diapers and baby care products, and Tempo for consumer tissue will also be introduced.
Share of Group, net sales 1309
PERSONAL CARE
| SEK m | 1309 | 1209 | % | 2013:3 | 2012:3 | % |
|---|---|---|---|---|---|---|
| Net sales | 20,041 | 19,261 | 4 | 6,673 | 6,490 | 3 |
| Operating surplus | 3,113 | 2,975 | 5 | 1,012 | 1,043 | -3 |
| Operating profit* | 2,420 | 2,296 | 5 | 804 | 847 | -5 |
| Operating margin, %* | 12.1 | 11.9 | 12.0 | 13.1 | ||
| Operating cash flow | 2,340 | 2,824 | 1,116 | 1,260 |
*) Excluding restructuring costs, which are reported as items affecting comparability outside of the business area.
January–September 2013 compared with corresponding period a year ago Net sales rose 4% (8% excluding exchange rate effects) to SEK 20,041m (19,261). Higher volumes and acquisitions each increased sales by 4%. In emerging markets, sales rose 13% excluding exchange rate effects.
Sales of incontinence care products under the globally leading TENA brand rose 6%, excluding exchange rate effects, driven mainly by emerging markets and favorable growth in Western Europe. Sales of baby diapers rose 5%, excluding exchange rate effects, mainly related to Eastern Europe and acquisition in Asia. Sales of feminine care products rose 7%, excluding exchange rate effects, mainly attributable to emerging markets.
Operating profit excluding items affecting comparability was 5% higher than a year ago (9% excluding exchange rate effects) and amounted to SEK 2,420m (2,296). Profit was favorably affected by higher volumes, cost savings and acquisitions. Investments in increased marketing activities led to higher volumes, but have weighed down earnings. Higher raw material costs and exchange rate effects had a negative effect on profit.
The operating cash surplus amounted to SEK 3,122m (2,989). Operating cash flow decreased to SEK 2,340m (2,824) as a result of a higher level of working capital and increased investments.
Third quarter 2013 compared with third quarter 2012
Net sales rose 3% (5% excluding exchange rate effects) to SEK 6,673m (6,490). Higher volumes increased sales by 5%.
Sales of incontinence care products under the globally leading TENA brand rose 5%, excluding exchange rate effects, driven mainly by Western Europe and emerging markets. Sales of baby diapers decreased by 3%, excluding exchange rate effects. The decrease is mainly attributable to lower sales in Europe. Sales of feminine care products rose 10%, excluding exchange rate effects, mainly attributable to emerging markets.
Operating profit excluding items affecting comparability decreased by 5% (3% excluding exchange rate effects) to SEK 804m (847). Earnings were favorably affected by higher volumes, higher prices and cost savings. Investments in increased marketing activities led to higher volumes, but have weighed down earnings. Higher raw material costs and negative exchange rate effects reduced earnings.
Share of Group, operating profit 1309
Operating profit and margin
Deviations, operating profit (%) 1309 vs. 1209 5
| -3 |
|---|
| 14 |
| -2 |
| 0 |
| -4 |
| 0 |
Share of Group, net sales 1309
Share of Group, operating profit 1309
TISSUE
| SEK m | 1309 | 1209 | % | 2013:3 | 2012:3 | % |
|---|---|---|---|---|---|---|
| Net sales | 34,922 | 29,915 | 17 | 11,642 | 11,333 | 3 |
| Operating surplus | 5,879 | 4,775 | 23 | 2,122 | 1,834 | 16 |
| Operating profit* | 4,028 | 3,221 | 25 | 1,498 | 1,275 | 17 |
| Operating margin, %* | 11.5 | 10.8 | 12.9 | 11.3 | ||
| Operating cash flow | 3,745 | 4,128 | 1,730 | 1,579 |
*) Excluding restructuring costs, which are reported as items affecting comparability outside of the business area.
Cost savings related to the acquisition of Georgia-Pacific's European tissue operations amounted to SEK 260m during the first nine months of 2013. The savings totaled SEK 120m during the third quarter of 2013, corresponding to an annual rate of approximately EUR 55m. Total cost savings are expected to amount to EUR 125m with full effect in 2016. The program is progressing according to plan.
January–September 2013 compared with corresponding period a year ago Net sales rose 17% (22% excluding exchange rate effects and divestments) to SEK 34,922m (29,915). Higher volumes increased sales by 5%. Acquisitions increased sales by 17%, while divestments reduced sales by 1%. Sales in emerging markets rose 15%, excluding exchange rate effects.
Sales of consumer tissue rose 23%, excluding exchange rate effects, mainly related to acquisitions in Europe and Latin America.
Sales of AFH tissue rose 21%, excluding exchange rate effects, mainly related to acquisition in Europe.
Operating profit excluding items affecting comparability improved by 25% (31% excluding exchange rate effects and divestments) to SEK 4,028m (3,221). Acquisitions, higher volumes and cost savings contributed to the earnings improvement. Acquisitions accounted for 13 percentage points of the earnings improvement. Higher energy costs and exchange rate effects reduced earnings.
The operating cash surplus increased to SEK 5,872m (4,826). Operating cash flow decreased to SEK 3,745m (4,128). The higher operating cash surplus did not compensate for a higher level of tied-up working capital and increased investments.
Third quarter 2013 compared with third quarter 2012
Net sales rose 3% (8% excluding exchange rate effects and divestments), to SEK 11,642m (11,333). Higher volumes and prices increased sales by 4% and 1%, respectively. Sales increased by 3% on account of the fact that the acquisition of Georgia-Pacific's European operations did not affect sales for the entire corresponding quarter in 2012. Divestments reduced sales by 4%.
Sales of consumer tissue increased by 6%, excluding exchange rate effects and divestments. The increase in sales is mainly attributable to emerging markets.
Sales of AFH tissue rose 12%, excluding exchange rate effects. The increase is mainly attributable to the fact that the acquisition of Georgia-Pacific's European operations did not affect sales for the entire corresponding quarter in 2012.
Operating profit excluding items affecting comparability rose 17% (22% excluding exchange rate effects and divestments) to SEK 1,498m (1,275). Higher volumes and prices along with cost savings had a positive effect on profit. Divestments had a negative effect on operating profit by 2%. Higher raw material and energy costs along with exchange rate effects reduced profit.
54%
Operating profit and margin
| Deviations, operating profit (%) | |
|---|---|
| 1309 vs. 1209 | 25 |
| Price/mix | -1 |
|---|---|
| Volume | 10 |
| Raw material | 0 |
| Energy | -3 |
| Currency | -5 |
| Other | 24 |
Share of Group, net sales 1309
Share of Group, operating profit 1309
Operating profit and margin
Deviations, operating profit (%) 1309 vs. 1209 -11
| Price/mix* | -49 |
|---|---|
| Volume | 1 |
| Raw material | 17 |
| Energy | -11 |
| Currency | 0 |
| Other | 31 |
*Price/mix includes exchange rate effects of approximately -20% (SEK -205m).
FOREST PRODUCTS
| SEK m | 1309 | 1209 | % | 2013:3 | 2012:3 | % |
|---|---|---|---|---|---|---|
| Deliveries | ||||||
| - Publication papers, thousand tonnes* | 766 | 1,164 | -34 | 212 | 398 | -47 |
| - Solid-wood products, thousand m3 | 1,684 | 1,578 | 7 | 544 | 484 | 12 |
| - Kraftliner products, thousand tonnes | 551 | 592 | -7 | 178 | 181 | -2 |
| - Pulp products, thousand tonnes | 381 | 383 | -1 | 135 | 128 | 5 |
| Net sales | 11,879 | 14,164 | -16 | 3,843 | 4,513 | -15 |
| Operating surplus | 1,888 | 2,222 | -15 | 720 | 677 | 6 |
| Operating profit** | 927 | 1,045 | -11 | 420 | 281 | 49 |
| Operating margin, %** | 7.8 | 7.4 | 10.9 | 6.2 | ||
| Operating cash flow | 593 | 1,069 | 176 | 583 |
*) Adjusted for the divestments of Aylesford and Laakirchen, deliveries were unchanged and increased by 3%, respectively.
**) Excluding restructuring costs, which are reported as items affecting comparability outside of the business area.
The ongoing efficiency program led to an earnings improvement of SEK 305m for the first nine months of the year. The earnings improvement during the third quarter amounted to SEK 160m, corresponding to an annual rate of approximately SEK 640m. The total earnings improvement is expected to amount to SEK 1,300m with full effect in 2015. The program is progressing according to plan.
January–September 2013 compared with corresponding period a year ago
Net sales decreased by 16% (2% excluding divestments) to SEK 11,879m (14,164). Higher volumes increased sales by 2%. Lower prices (including exchange rate effects) reduced sales by 4%. Divestments reduced sales by 14%.
Sales of publication paper decreased as a result of lower prices (including exchange rate effects) and divestments. Higher volumes had a positive effect on sales of publication paper. Sales of kraftliner decreased as a result of lower volumes that were not fully compensated by higher prices. Sales of solid-wood products increased as a result of higher volumes that were partly offset by lower prices (including exchange rate effects). Sales of pulp decreased as a result of lower volumes and prices (including exchange rate effects).
Operating profit excluding items affecting comparability decreased by 11% to SEK 927m (1,045). The lower profit is mainly attributable to lower prices, negative exchange rate effects of SEK 205m related to the stronger Swedish krona, higher energy costs and costs for extended maintenance shutdowns. Cost savings and lower raw material costs had a positive effect on profit. Earnings effects related to land swaps had a favorable effect on operating profit by SEK 128m (67), of which SEK 7m (35) during the third quarter.
The operating cash surplus was SEK 1,321m (1,661), and operating cash flow totaled SEK 593m (1,069).
Third quarter 2013 compared with third quarter 2012
Net sales decreased by 15% (increase of 6% excluding divestments) to SEK 3,843m (4,513). Higher volumes and prices increased sales by 5% and 1%, respectively. Divestments reduced sales by 21%.
Sales of publication paper decreased as a result of lower prices (including exchange rate effects) and divestments. Sales of kraftliner rose as a result of higher prices. Sales of solid-wood products and pulp rose as a result of higher prices and volumes.
Operating profit excluding items affecting comparability rose 49% to SEK 420m (281).The higher profit is mainly attributable to cost savings, higher prices and lower raw material costs. Profit was negatively affected by higher energy costs.
SHARE DISTRIBUTION
| September 30, 2013 | Class A | Class B | Total |
|---|---|---|---|
| Registered number of shares | 87,768,057 | 617,342,037 | 705,110,094 |
| - of which treasury shares | 2,767,605 | 2,767,605 |
At the end the reporting period the proportion of Class A shares was 12.4%. During the third quarter, at the request of shareholders a total of 2,532,715 Class A shares were converted to Class B shares. The total number of votes in the company is thereafter 1,495,022,607.
FUTURE REPORTS
The year-end report for 2013 will be published on January 29, 2014. SCA's 2013 Annual Report is expected to be published during the week of March 17, 2014.
In 2014, quarterly reports will be published on April 29, July 18 and October 29.
ANNUAL GENERAL MEETING
SCA's Annual General Meeting will be held at 3 p.m. (CET) on April 10, 2014, at the Stockholm Waterfront Congress Centre, Stockholm, Sweden.
INVITATION TO PRESS CONFERENCE ON Q3 INTERIM REPORT 2013
Media and analysts are invited to a press conference, where this interim report will be presented by Jan Johansson, President and CEO of SCA.
Time: 10:00 CET, Friday, October 18, 2013 Location: SCA's headquarters, Waterfront Building, Klarabergsviadukten 63, Stockholm, Sweden.
The presentation will be webcast at www.sca.com. To participate, call: +44 (0)20 7162 0077, +1 (334) 323-6201 or + 46 (0)8 5052 0110.
Stockholm, October 18, 2013 SVENSKA CELLULOSA AKTIEBOLAGET SCA (publ)
Jan Johansson President and CEO
For further information, please contact:
Johan Karlsson, Vice President Investor Relations, Corporate Communications, +46 8 788 51 30 Boo Ehlin, Vice President Media Relations, Corporate Communications, +46 8 788 51 36 Joséphine Edwall-Björklund, Senior Vice President, Corporate Communications, +46 8 788 52 34
NB
SCA discloses the information provided herein pursuant to the Securities Markets Act. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. Submitted for publication on October 18, 2013, at 8.00 CET. This report has not been reviewed by the company's auditors.
OPERATING CASH FLOW ANALYSIS
| SEK m | 1309 | 1209 |
|---|---|---|
| Operating cash surplus | 9,809 | 9,160 |
| Change in working capital | -1,019 | 430 |
| Current capital expenditures, net | -2,258 | -1,769 |
| Restructuring costs, etc. | -769 | -623 |
| Operating cash flow | 5,763 | 7,198 |
| Financial items | -745 | -971 |
| Income taxes paid | -1,084 | -687 |
| Other | 126 | 67 |
| Cash flow from current operations | 4,060 | 5,607 |
| Acquisitions | -940 | -14,709 |
| Strategic capital expenditures, fixed assets | -1,213 | -1,363 |
| Divestments | 1,554 | 17,763 |
| Cash flow before dividend | 3,461 | 7,298 |
| Dividend | -3,193 | -2,982 |
| Cash flow after dividend | 268 | 4,316 |
| Net cash flow from disposal group | 0 | 468 |
| Net cash flow | 268 | 4,784 |
| Net debt at the start of the period | -32,927 | -36,648* |
| Net cash flow | 268 | 4,784 |
| Remeasurement to equity | 1,382 | -2,027 |
| Currency effects | 231 | 21 |
| Effect of reclassification of operating liability** | -186 | 0 |
| Net debt at the end of the period | -31,232 | -33,870 |
| Debt/equity ratio | 0.52 | 0.59 |
| Debt payment capacity, % | 36 | 39 |
* Including disposal group
** Provision for payroll tax has been reclassified to net debt under IAS 19.
CASH FLOW STATEMENT
| SEK m | 1309 | 1209 | 1309* | 1209* |
|---|---|---|---|---|
| Operating activities | ||||
| Profit before tax | 5,116 | 4,491 | ||
| Adjustment for non-cash items1 | 3,268 | 4,229 | ||
| 8,384 | 8,720 | - | 1,087 | |
| Paid tax | -1,084 | -797 | - | -110 |
| Cash flow from operating activities | ||||
| before changes in working capital | 7,300 | 7,923 | - | 977 |
| Cash flow from changes in working capital | ||||
| Change in inventories | 128 | 220 | ||
| Change in operating receivables | -571 | -1,182 | - | -213 |
| Change in operating liabilities | -576 | 1,180 | ||
| Cash flow from operating activities | 6,281 | 8,141 | - | 764 |
| Investing activities | ||||
| Acquisition of operations | 88 | -14,307 | ||
| Sold operations | 1,336 | 17,033 | ||
| Acquisition tangible and intangible assets | -3,787 | -3,629 | ||
| Sale of tangible assets | 316 | 207 | ||
| Payment of loans to external parties | 0 | -101 | ||
| Repayment of loans from external parties | 377 | 0 | ||
| Cash flow from investing activities | -1,670 | -797 | - | -321 |
| Financing activities | ||||
| Acquisition of non-controlling interests | -1,028 | 0 | ||
| Borrowings | 155 | 0 | ||
| Amortization of debt | 0 | -4,728 | ||
| Dividends paid | -3,193 | -2,984 | ||
| Cash flow from financing activities | -4,066 | -7,712 | - | -41 |
| Cash flow for the period | 545 | -368 | - | 402 |
| Cash and cash equivalents at the beginning of the year | 2,017 | 2,752 | ||
| Exchange rate differences in cash and cash equivalents | -44 | -61 | ||
| Cash and cash equivalents at the end of the period | 2,518 | 2,323 | ||
| *Of which, the packaging operations divested June 2012. | ||||
| Cash flow from operating activities per share, SEK | 8.91 | 11.55 | ||
| Reconciliation with operating cash flow analysis | ||||
| Cash flow for the period | 545 | -368 | ||
| Deducted items: | ||||
| Payment of loans to external parties | 0 | 101 | ||
| Repayment of loans from external parties | -377 | 0 | ||
| Borrowings | -155 | 0 | ||
| Amortization of debt | 0 | 4,728 | ||
| Added items: | ||||
| Net debt in acquired and divested operations | 218 | 323 | ||
| Accrued interest | 37 | 0 | ||
| Net cash flow according to operating cash flow analysis | 268 | 4,784 | ||
| 1 Depreciation and impairment, fixed assets |
3,825 | 4,131 | ||
| Fair-value measurement/net growth of forest assets | -442 | -564 | ||
| Unpaid related to efficiency programs | 396 | 129 | ||
| Profit or Loss from disposals | 120 | 851 | ||
| Payments related to efficiency programs, already recognized | -435 | -249 | ||
| Other | -196 | -69 | ||
| Total | 3,268 | 4,229 |
STATEMENT OF PROFIT OR LOSS
| SEK m | 2013:3 | 2012:3 | 2013:2 | 1309 | 1209 |
|---|---|---|---|---|---|
| Net sales | 22,046 | 22,200 | 22,145 | 66,577 | 61,963 |
| Cost of goods sold 1 | -16,383 | -17,038 | -16,700 | -50,156 | -46,838 |
| Gross profit | 5,663 | 5,162 | 5,445 | 16,421 | 15,125 |
| Sales, general and administration 1 | -3,212 | -2,955 | -3,324 | -9,660 | -8,966 |
| Items affecting comparability 2 | -233 | -1,031 | -373 | -1,024 | -1,441 |
| Share of profits of associates | 73 | 78 | 35 | 124 | 65 |
| Operating profit | 2,291 | 1,254 | 1,783 | 5,861 | 4,783 |
| Financial items | -268 | -324 | -213 | -745 | -971 |
| Profit before tax | 2,023 | 930 | 1,570 | 5,116 | 3,812 |
| Tax | -574 | -560 | -416 | -1,378 | -1,396 |
| Net profit for the period continued operations | 1,449 | 370 | 1,154 | 3,738 | 2,416 |
| Net profit for the period from disposal group | 0 | 0 | 0 | 0 | 503 |
| Net profit for the period | 1,449 | 370 | 1,154 | 3,738 | 2,919 |
| Earnings attributable to: | |||||
| Owners of the parent | 1,449 | 356 | 1,143 | 3,711 | 2,870 |
| Non-controlling interests | 0 | 14 | 11 | 27 | 49 |
| Earnings per share, SEK - owners of the parent total operations | |||||
| - before dilution effects | 2.06 | 0.51 | 1.63 | 5.28 | 4.09 |
| - after dilution effects | 2.06 | 0.51 | 1.63 | 5.28 | 4.09 |
| Earnings per share, SEK - owners of the parent continued operations | |||||
| - before dilution effects | 2.06 | 0.51 | 1.63 | 5.28 | 3.37 |
| - after dilution effects | 2.06 | 0.51 | 1.63 | 5.28 | 3.37 |
| Calculation of earnings per share | 2013:3 | 2012:3 | 2013:2 | 1309 | 1209 |
| Earnings attributable to owners of the parent | 1,449 | 356 | 1,143 | 3,711 | 2,870 |
| Average no. of shares before dilution, millions | 702.3 | 702.3 | 702.3 | 702.3 | 702.3 |
| Average no. of shares after dilution, millions | 702.3 | 702.3 | 702.3 | 702.3 | 702.3 |
| 1 Of which, depreciation | -1,222 | -1,270 | -1,208 | -3,672 | -3,624 |
| 2 Distribution of items affecting comparability | |||||
| Distribution of restructuring costs, etc. per function | |||||
| Cost of goods sold | -63 | -35 | -62 | -213 | -47 |
| Sales, general and administration Impairment, etc. |
-160 -10 |
-159 -837 |
-310 -1 |
-648 -163 |
-557 -837 |
| Total items affecting comparability | -233 | -1,031 | -373 | -1,024 | -1,441 |
| Gross margin | 25.7 | 23.3 | 24.6 | 24.7 | 24.4 |
| Operating margin | 10.4 | 5.6 | 8.1 | 8.8 | 7.7 |
| Financial net margin | -1.2 | -1.5 | -1.0 | -1.1 | -1.6 |
| Profit margin | 9.2 | 4.1 | 7.1 | 7.7 | 6.1 |
| Tax | -2.6 | -2.5 | -1.9 | -2.1 | -2.3 |
| Net margin * | 6.6 | 1.6 | 5.2 | 5.6 | 3.8 |
| * Excluding Net profit for the period from disposal group | |||||
| Excluding items affecting comparability: | 2013:3 | 2012:3 | 2013:2 | 1309 | 1209 |
| Gross margin | 25.7 | 23.3 | 24.6 | 24.7 | 24.4 |
| Operating margin | 11.4 | 10.3 | 9.7 | 10.3 | 10.0 |
| Financial net margin | -1.2 | -1.5 | -1.0 | -1.1 | -1.6 |
| Profit margin | 10.2 | 8.8 | 8.7 | 9.2 | 8.4 |
| Tax | -2.9 | -2.7 | -2.2 | -2.4 | -2.4 |
| Net margin * | 7.3 | 6.1 | 6.5 | 6.8 | 6.0 |
* Excluding Net profit for the period from disposal group
STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
| SEK m | 2013:3 | 2012:3 | 2013:2 | 1309 | 1209 |
|---|---|---|---|---|---|
| Profit for the period | 1,449 | 370 | 1,154 | 3,738 | 2,919 |
| Other comprehensive income for the period | |||||
| Items never reclassified subsequently to profit or loss | |||||
| Actuarial gains/losses on defined benefit pension plans | -421 | -508 | 842 | 1,208 | -2,173 |
| Income tax relating to components of other comprehensive income | 127 | -38 | -226 | -309 | 468 |
| -294 | -546 | 616 | 899 | -1,705 | |
| Items that may be reclassified subsequently to profit or loss | |||||
| Available-for-sale financial assets | 68 | 58 | -42 | 174 | 132 |
| Cash flow hedges | 98 | 38 | -223 | 9 | 46 |
| Exchange differences on translating foreign operations | -1,036 | -2,895 | 1,940 | -510 | -4,346 |
| Gains/losses from hedges of net investments in foreign operations | 204 | 1,397 | -778 | 17 | 2,027 |
| Income tax relating to components of other comprehensive income | -66 | 7 | 226* | -254* | -19 |
| -732 | -1,395 | 1,123 | -564 | -2,160 | |
| Other comprehensive income for the period, net of tax | -1,026 | -1,941 | 1,739 | 335 | -3,865 |
| Total comprehensive income for the period | 423 | -1,571 | 2,893 | 4,073 | -946 |
| Total comprehensive income attributable to: | |||||
| Owners of the parent | 425 | -1,562 | 2,841 | 4,023 | -963 |
| Non-controlling interests | -2 | -9 | 52 | 50 | 17 |
| *) Whereof a correction of previous year | -249 | -249 |
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
| SEK m | 1309 | 1209 |
|---|---|---|
| Attributable to owners of the parent | ||
| Opening balance, January 1 | 59,706 | 60,752 |
| Total comprehensive income for the period | 4,023 | -963 |
| Dividend | -3,161 | -2,950 |
| Acquisition of non-controlling interests | -666 | 0 |
| Revaluation effect of non-controlling interests | -3 | -3 |
| Closing balance | 59,899 | 56,836 |
| Non-controlling interests | ||
| Opening balance, January 1 | 458 | 539 |
| Total comprehensive income for the period | 50 | 17 |
| Dividend | -32 | -34 |
| Acquisition of non-controlling interests | -335 | -7 |
| Closing balance | 141 | 515 |
| Total equity, closing balance | 60,040 | 57,351 |
CONSOLIDATED BALANCE SHEET
| SEK m | Note | September 30, 2013 | December 31, 2012 |
|---|---|---|---|
| Assets | |||
| Goodwill | 11,610 | 12,169 | |
| Other intangible assets | 4,971 | 5,460 | |
| Tangible assets | 74,490 | 74,205 | |
| Shares and participations | 2,589 | 2,517 | |
| Non-current financial assets | 4 | 3,271 | 3,614 |
| Other non-current receivables | 4 | 1,700 | 905 |
| Total non-current assets | 98,631 | 98,870 | |
| Operating receivables and inventories | 4 | 27,604 | 28,539 |
| Current financial assets | 4 | 144 | 168 |
| Non-current assets held for sale | 118 | 1,937 | |
| Cash and cash equivalents | 2,518 | 2,017 | |
| Total current assets | 30,384 | 32,661 | |
| Total assets | 129,015 | 131,531 | |
| Equity | |||
| Owners of the parent | 59,899 | 59,706 | |
| Non-controlling interests | 141 | 458 | |
| Total equity | 60,040 | 60,164 | |
| Liabilities | |||
| Provisions for pensions | 3,512 | 4,861 | |
| Other provisions | 9,637 | 9,107 | |
| Non-current financial liabilities | 4 | 27,115 | 23,759 |
| Other non-current liabilities | 4 | 802 | 1,013 |
| Total non-current liabilities | 41,066 | 38,740 | |
| Current financial liabilities1 | 4 | 6,424 | 9,955 |
| Other current liabilities | 4 | 21,485 | 22,672 |
| Total current liabilities | 27,909 | 32,627 | |
| Total liabilities | 68,975 | 71,367 | |
| Total equity and liabilities | 129,015 | 131,531 | |
| 1 Committed credit lines amount to SEK 17,660m of which unutilized SEK 17,660m. |
|||
| Debt/equity ratio | 0.52 | 0.55 | |
| Visible equity/assets ratio | 46% | 45% | |
| Return on capital employed | 8% | 7% | |
| Return on equity | 8% | 8% | |
| Excluding items affecting comparability: | |||
| Return on capital employed | 10% | 10% | |
| Return on equity | 11% | 12% | |
| Equity per share, SEK | 85 | 85 | |
| Capital employed | 91,272 | 93,091 | |
| - of which working capital | 6,970 | 6,625 | |
| Provisions for restructuring costs are included in the balance sheet as follows: | |||
| - Other provisions* | 635 | 613 | |
| - Operating liabilities | 544 | 630 | |
| *) of which, provision for tax risks | 482 | 482 | |
| Net debt | 31,232 | 32,927 | |
| Total Equity | 60,040 | 60,164 |
NET SALES
| SEK m | 1309 | 1209 | 2013:3 | 2013:2 | 2013:1 2012:4 2012:3 | 2012:2 | ||
|---|---|---|---|---|---|---|---|---|
| Personal Care | 20,041 | 19,261 | 6,673 | 6,764 | 6,604 | 7,033 | 6,490 | 6,530 |
| Tissue | 34,922 | 29,915 | 11,642 | 11,650 | 11,630 12,460 11,333 | 9,461 | ||
| Forest Products | 11,879 | 14,164 | 3,843 | 3,788 | 4,248 | 4,119 | 4,513 | 4,868 |
| Other | 121 | 1,046 | 5 | 33 | 83 | 222 | 248 | 418 |
| Intra-group deliveries | -386 | -2,423 | -117 | -90 | -179 | -389 | -384 | -1,004 |
| Total net sales | 66,577 | 61,963 | 22,046 | 22,145 | 22,386 23,445 22,200 | 20,273 |
OPERATING PROFIT
| SEK m | 1309 | 1209 | 2013:3 | 2013:2 | 2013:1 2012:4 2012:3 | 2012:2 | ||
|---|---|---|---|---|---|---|---|---|
| Personal Care | 2,420 | 2,296 | 804 | 806 | 810 | 884 | 847 | 781 |
| Tissue | 4,028 | 3,221 | 1,498 | 1,295 | 1,235 | 1,419 | 1,275 | 1,021 |
| Forest Products | 927 | 1,045 | 420 | 250 | 257 | 318 | 281 | 433 |
| Other | -490 | -338 | -198 | -195 | -97 | -199 | -118 | -130 |
| Total operating profit 1 | 6,885 | 6,224 | 2,524 | 2,156 | 2,205 | 2,422 | 2,285 | 2,105 |
| Financial items | -745 | -971 | -268 | -213 | -264 | -293 | -324 | -316 |
| Profit before tax 1 | 6,140 | 5,253 | 2,256 | 1,943 | 1,941 | 2,129 | 1,961 | 1,789 |
| Tax | - 1,628 |
- 1,481 |
-636 | -492 | -500 | 853 | -589 | -479 |
| Net profit for the period from disposal group | 0 | 503 | 0 | 0 | 0 | 0 | 0 | 234 |
| Net profit for the period 2 | 4,512 | 4,275 | 1,620 | 1,451 | 1,441 | 2,982 | 1,372 | 1,544 |
| 1 Excluding items affecting comparability before tax amounting to: | -1,024 | -1,441 | -233 | -373 | -418 | -1,193 | -1,031 | -260 |
| 2 Excluding items affecting comparability after tax amounting to: |
-774 | -1,356 | -171 | -297 | -306 | -901 | -1,002 | -226 |
OPERATING MARGIN
| % | 1309 | 1209 | 2013:3 | 2013:2 | 2013:1 2012:4 2012:3 | 2012:2 | ||
|---|---|---|---|---|---|---|---|---|
| Personal Care | 12.1 | 11.9 | 12.0 | 11.9 | 12.3 | 12.6 | 13.1 | 12.0 |
| Tissue | 11.5 | 10.8 | 12.9 | 11.1 | 10.6 | 11.4 | 11.3 | 10.8 |
| Forest Products | 7.8 | 7.4 | 10.9 | 6.6 | 6.0 | 7.7 | 6.2 | 8.9 |
STATEMENT OF PROFIT OR LOSS
| SEK m | 2013:3 | 2013:2 | 2013:1 | 2012:4 | 2012:3 |
|---|---|---|---|---|---|
| Net sales | 22,046 | 22,145 | 22,386 | 23,445 | 22,200 |
| Cost of goods sold | -16,383 | -16,700 | -17,073 | -17,611 | -17,038 |
| Gross profit | 5,663 | 5,445 | 5,313 | 5,834 | 5,162 |
| Sales, general and administration | -3,212 | -3,324 | -3,124 | -3,506 | -2,955 |
| Items affecting comparability | -233 | -373 | -418 | -1,193 | -1,031 |
| Share of profits of associates | 73 | 35 | 16 | 94 | 78 |
| Operating profit | 2,291 | 1,783 | 1,787 | 1,229 | 1,254 |
| Financial items | -268 | -213 | -264 | -293 | -324 |
| Profit before tax | 2,023 | 1,570 | 1,523 | 936 | 930 |
| Taxes | -574 | -416 | -388 | 1,145 | -560 |
| Net profit for the period from disposal group | 0 | 0 | 0 | 0 | 0 |
| Net profit for the period | 1,449 | 1,154 | 1,135 | 2,081 | 370 |
INCOME STATEMENT PARENT COMPANY
| SEK m | 1309 | 1209 |
|---|---|---|
| Administrative expenses | -579 | -422 |
| Other operating income | 279 | 126 |
| Other operating expenses | -161 | -126 |
| Operating profit | -461 | -422 |
| Financial items | 354 | 989 |
| Profit before tax | -107 | 567 |
| Tax | 432 | 664 |
| Net profit for the period | 325 | 1,231 |
BALANCE SHEET PARENT COMPANY
| SEK m | September 30, 2013 | December 31, 2012 |
|---|---|---|
| Intangible fixed assets | 1 | 1 |
| Tangible fixed assets | 6,769 | 6,724 |
| Financial fixed assets | 124,278 | 124,804 |
| Total fixed assets | 131,048 | 131,529 |
| Total current assets | 835 | 3,480 |
| Total assets | 131,883 | 135,009 |
| Restricted equity | 10,996 | 10,996 |
| Unrestricted equity | 36,506 | 39,342 |
| Total equity | 47,502 | 50,338 |
| Untaxed reserves | 181 | 181 |
| Provisions | 1,205 | 1,194 |
| Non-current liabilities | 20,849 | 15,593 |
| Current liabilities | 62,146 | 67,703 |
| Total equity, provisions and liabilities | 131,883 | 135,009 |
NOTES
1 ACCOUNTING PRINCIPLES
This interim report has been prepared in accordance with IAS 34 and recommendation RFR 1 of the Swedish Financial Reporting Board (RFR), and with regard to the Parent Company, RFR 2. The accounting principles applied correspond to those described in the 2012 Annual Report.
Effective January 1, 2013, SCA applies the following new or amended IFRSs:
- IAS 19 Employee Benefits
- IFRS 13 Fair Value Measurement
- IAS 1 Presentation of Financial Statements Recognition of items in other comprehensive income
The amendments in IAS 19 Employee Benefits consist mainly of the removal of the corridor approach and the replacement of interest expenses and the expected return on plan assets by a net interest figure calculated using the discounting rate, based on the net surplus or deficit in the defined-benefit plan. For SCA, which already applies immediate recognition of actuarial gains and losses, the amendment imposes a restriction insofar as the return on plan assets in profit or loss is limited to a predetermined discounting rate instead of the company's long-term expectation of the actual return on plan assets, which applied through 2012. For 2012, the amended interest calculation would have reduced profit for the period by SEK 205m. IFRS 13 Fair Value Measurement aims to improve consistency and reduce complexity in the application of fair value measurement by providing a precise definition and a shared source in IFRS for fair value measurements and associated disclosures. The requirements do not expand the area of application for when fair value is required to be used, but provide guidance on how it should be applied when other IFRSs already require or permit fair value measurement. The standard is not expected to have any material impact on the Group. Other changes are not expected to have any material impact on the Group's or Parent Company's result of operations, financial position or disclosures.
2 RISKS AND UNCERTAINTIES
SCA's risk exposure and risk management are described on pages 56–61 of the 2012 Annual Report. No significant changes have taken place that have affected the reported risks.
Risks in conjunction with company acquisitions are analyzed in the due diligence processes that SCA carries out prior to all acquisitions. In cases where acquisitions have been carried out that may affect the assessment of SCA's risk exposure, these are described under the heading "Other events" in interim reports.
Risk management processes
SCA's board decides on the Group's strategic direction, based on recommendations made by Group management. Responsibility for the long-term, overall management of strategic risks corresponds to the company's delegation structure, from the Board to the CEO and from the CEO to the business unit heads. This means that most operational risks are managed by SCA's business units at the local level, but that they are coordinated when considered necessary. The tools used in this coordination consist primarily of the business units' regular reporting and the annual strategy process, where risks and risk management are a part of the process.
SCA's financial risk management is centralized, as is the Group's internal bank for the Group companies' financial transactions and management of the Group's energy risks. Financial risks are managed in accordance with the Group's finance policy, which is adopted by SCA's board and which – together with SCA's energy risk policy – makes up a framework for risk management. Risks are aggregated and followed up on a regular basis to ensure compliance with these guidelines. SCA has also centralized other risk management.
SCA has a staff function for internal audit, which monitors compliance in the organization with the Group's policies.
3 RELATED PARTY TRANSACTIONS
No transactions have been carried out between SCA and related parties that had a material impact on the company's financial position and results of operations.
4 FINANCIAL INSTRUMENTS
Distribution by level for measurement at fair value
| Financial | |||||||
|---|---|---|---|---|---|---|---|
| Carrying | Measured at | Derivatives | Available | liabilities | |||
| amount in | fair value | used for | for-sale | measured at | |||
| the balance | through profit | hedge | financial | amortized | Of which fair | ||
| SEK m | sheet | or loss | accounting | assets | cost | value by level1 | |
| September 30, 2013 | 1 | 2 | |||||
| Derivatives | 1,030 | 289 | 741 | - | - | - | 1,030 |
| Non-current financial assets | 1,580 | - | - | 1,580 | - | 1,572 | 8 |
| Total assets | 2,610 | 289 | 741 | 1,580 | 0 | 1,572 | 1,038 |
| Derivatives | 558 | 166 | 392 | - | - | - | 558 |
| Financial liabilities | |||||||
| Current financial liabilities | 6,333 | 519 | - | - | 5,814 | - | 519 |
| Non-current financial liabilities | 26,846 | 15,465 | - | - | 11,381 | - | 15,465 |
| Total liabilities | 33,737 | 16,150 | 392 | - | 17,195 | 17,195 | 16,542 |
| December 31, 2012 | |||||||
| Derivatives | 1,400 | 397 | 1,003 | - | - | - | 1,400 |
| Non-current financial assets | 1,448 | - | - | 1,448 | - | 1,440 | 8 |
| Total assets | 2,848 | 397 | 1,003 | 1,448 | - | 1,440 | 1,408 |
| Derivatives | 484 | 156 | 328 | - | - | - | 484 |
| Financial liabilities | |||||||
| Current financial liabilities | 9,834 | - | - | - | 9,834 | - | - |
| Non-current financial liabilities | 23,583 | 12,943 | - | - | 10,640 | - | 12,943 |
| Total liabilities | 33,901 | 13,099 | 328 | - | 20,474 | - | 13,427 |
1 No financial instruments have been classified to level 3
The fair value of trade receivables, other current and non-current receivables, cash and cash equivalents, trade payables and other current and non-current liabilities is estimated to be equal to their book value. The total fair value of financial liabilities amounts to SEK 33,683m (33,979).
No transfers between level 1 and 2 were made during the period.
The fair value of financial instruments is calculated based on current market quotations on the balance sheet date. The value of derivatives is based on published prices in an active market. The fair value of debt instruments is set using valuation models, such as discounting of future cash flows to quoted market interest rates for the respective durations.
5 ACQUISITIONS AND DIVESTMENTS
SCA completed the divestment of its Austrian publication paper mill on April 2, 2013. During the period, this operation generated sales of SEK 688m and an operating profit of SEK 34m. The operation was deconsolidated as from the month of April.
On January 17, 2012, an agreement was reached with DS Smith on the divestment of SCA's packaging operations, excluding the two kraftliner mills in Sweden. The purchase price was EUR 1,700m on a debt-free basis. The deal was approved by the European Commission Competition Authority on May 25, 2012, and was completed on June 30, 2012. The operations were deconsolidated on June 30, 2012. The sales price will be adjusted following reconciliation of working capital, etc.
A purchase price allocation is preliminary until 12 months after an acquisition, at which time it is confirmed. When adjusting a purchase price allocation, the income statements and balance sheets are adjusted for the comparison period. The acquisition balance for Everbeauty, which was acquired on June 1, 2012, has been confirmed in accordance with the preliminary purchase price allocation.
SCA Hygiene Products SE (Societas Europeas), formerly PWA, has become a wholly owned subsidiary of SCA after the shares outstanding were acquired through a compulsory redemption from non-controlling interests (minority). The consideration transferred amounted to approximately SEK 1bn.
In connection with SCA's acquisition of Georgia-Pacific's European tissue operations in 2012, the European Commission required divestments of certain consumer tissue operations that previously belonged to Georgia-Pacific in the UK, Ireland and Benelux, and certain operations in the Nordic countries. These operations generated sales of SEK 621m and an operating profit of SEK 79m during the period. The operations were fully deconsolidated after the second quarter of 2013.
The previous, preliminarily reported purchase price allocation for Georgia-Pacific has now been confirmed. In the definitive purchase price allocation, the value of non-current assets and associated deferred taxes has been adjusted, and it has been determined that previously unutilized loss carryforwards can be utilized to reduce previously reported goodwill.
| Purchase price allocation Georgia-Pacific | Preliminary | assumptions | Final | |
|---|---|---|---|---|
| SEK m | ||||
| Intangible assets | 2 493 | 2 493 | ||
| Non-current assets | 5 830 | 321 | 6 151 | |
| Current assets | 4 292 | -1 | 4 291 | |
| Cash and cash equivalents | 633 | 633 | ||
| Net debt excluding cash and cash equivalents | -476 | -476 | ||
| Provisions and other non-current liabilities | -1 193 | -47 | -1 240 | |
| Operating liabilities | -2 775 | -21 | -2 796 | |
| Non-current assets held for sale | 750 | 750 | ||
| Net identifiable assets and liabilities | 9 554 | 252 | 9 805 | |
| Goodwill | 1 960 | -252 | 1 708 | |
| Consideration paid | 11 514 | 0 | 11 514 | |
| Consideration paid | -11 514 | -11 514 | ||
| Cash and cash equivalents in acquired operations | 633 | 633 | ||
| Effect on Group's cash and cash equivalents (Consolidated cash flow | ||||
| statement) | -10 881 | -10 881 | ||
| Acquired net debt excluding cash and cash equivalents | -476 | -476 | ||
| Acquisition of operations including net debt taken over (Consolidated | ||||
| operating cash flow analysis) | -11 357 | -11 357 |